Symptoms May Persist After Pediatric SARS-CoV-2 Infection
A large cross-sectional study offered a survey of long COVID symptoms in children who have been infected with SARS-CoV-2.
A large cross-sectional study offered a survey of long COVID symptoms in children who have been infected with SARS-CoV-2.
The combined SARS-CoV-2 seroprevalence from infection or vaccination reached an estimated 94.7% by December 2021.
Researchers compared Medicare Part D spending for 89 drugs to prices for their generic equivalents sold by Mark Cuban Cost Plus Drug Company.
Researchers assessed the association between dexamethasone treatment and the occurrence of superinfections among patients with severe COVID-19.
Numbers of new patient accruals and newly activated trials decreased early on, followed by a progressive recovery and return to levels that were higher than normal.
Only 5.7% of hospitals met both requirements, which are a machine-readable file for required price types and an accessible display for at least 300 shoppable items.
Researchers assessed the safety and immunogenicity of Nanocovax, a novel COVID-19 vaccine candidate.
The study evaluated Paxlovid in both vaccinated and unvaccinated patients with COVID-19 at standard risk for progressing to severe disease.
There was a higher risk for DLLR seen among women and among individuals aged 30 to 69 years.
Patients trust that what they tell their doctors will remain confidential, but under certain specific circumstances, the doctors may be obligated to breach that trust.